Enhanced cell growth and motility, associated with elevated S100A4 expression, was shown to increase the metastatic potential of cancer cells among a variety of malignancies, such as breast cancer, lung cancer, or CRC (Bresnick et al., 2015). Here, S100A4 is linked to colorectal carcinoma.